Elboraey Asmaa Nabil, Abo-Almaged Hanan Hassan, El-Ashmawy Ahmed Abd El-Rahman, Abdou Aya Rashad, Moussa Amani Ramadan, Emara Laila Hassanian, El-Masry Hossam Mohammed, El Bassyouni Gehan El-Tabie, Ramzy Magda Ismail
Fixed and Removable Prosthodontics Department, National Research Centre, 33 El Buhouth Street, Dokki, P.O.12622 Cairo, Egypt.
Refractories, Ceramics and Building Materials Department, National Research Centre, 33 El Buhouth Street, Dokki, P.O.12622, Cairo, Egypt.
Adv Pharm Bull. 2021 Jan;11(1):86-95. doi: 10.34172/apb.2021.009. Epub 2020 Nov 7.
This study aimed to evaluate the biological and mechanical properties of the poly(methyl methacrylate) (PMMA) denture base material as a vehicle incorporating novel hydroxyapatite nanoparticles (HA-NP) loaded with metronidazole (MZ) drug. HA-NP was prepared via wet-chemical-method, characterized by XRD, SEM/EDX, TEM, Fourier-transform infrared spectroscopy (FTIR), as well as the measurement of surface area and pore-size distribution. Four drug delivery formulas were prepared in the form of discs (10 x 2 mm) as follows: F1 (MZ/ HA-NP/PMMA), F2 (HA-NP/ PMMA), F3 (control-PMMA) and F4 (MZ/PMMA). Characterization of all formulas was performed using differential scanning calorimetry (DSC) and FTIR. MZ release rate, antimicrobial properties against three oral pathogens, cytotoxicity (MTT assay) and surface micro-hardness were also assessed. Statistical analysis of data was performed using one-way ANOVA test ( < 0.05). DSC thermograms showed compatibility among MZ, HA-NP and PMMA along with physical stability over 6 months storage period at room temperature. FTIR spectroscopy proved the absence of any possible chemical interaction with MZ. MZ-HA-NP/PMMA formula showed relatively better drug release compared to MZ-PMMA. Both formulas showed statistically significant antimicrobial potentials against two microbial strains. MTT demonstrated reduction in cell cytotoxicity after 96 hours with the least value for HA-NP. Surface micro-hardness revealed non-significant reduction compared with the control PMMA. A novel biocompatible drug nanocarrier (HA-NP) was developed and incorporated in PMMA denture base material as a vehicle to allow prolonged sustained drug release to manage oral infections.
本研究旨在评估聚甲基丙烯酸甲酯(PMMA)义齿基托材料作为一种载有新型甲硝唑(MZ)药物的羟基磷灰石纳米颗粒(HA-NP)载体的生物学和机械性能。HA-NP通过湿化学法制备,采用X射线衍射(XRD)、扫描电子显微镜/能谱仪(SEM/EDX)、透射电子显微镜(TEM)、傅里叶变换红外光谱(FTIR)以及表面积和孔径分布测量进行表征。制备了四种盘状(10×2毫米)的药物递送配方,如下:F1(MZ/HA-NP/PMMA)、F2(HA-NP/PMMA)、F3(对照-PMMA)和F4(MZ/PMMA)。使用差示扫描量热法(DSC)和FTIR对所有配方进行表征。还评估了MZ释放率、对三种口腔病原体的抗菌性能、细胞毒性(MTT法)和表面显微硬度。使用单因素方差分析测试(<0.05)对数据进行统计分析。DSC热重曲线显示MZ、HA-NP和PMMA之间具有相容性,并且在室温下储存6个月期间具有物理稳定性。FTIR光谱证明不存在与MZ的任何可能化学相互作用。与MZ-PMMA相比,MZ-HA-NP/PMMA配方显示出相对更好的药物释放。两种配方对两种微生物菌株均显示出统计学上显著的抗菌潜力。MTT显示96小时后细胞毒性降低,HA-NP的值最小。表面显微硬度显示与对照PMMA相比降低不显著。开发了一种新型生物相容性药物纳米载体(HA-NP),并将其作为载体掺入PMMA义齿基托材料中,以实现药物的长期持续释放,从而管理口腔感染。